TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06131359

Intervention type: DIAGNOSTIC_TEST
Intervention: Fine wire EMG and Force Frame muscle strength testing
Description: Insertion of fine wires for EMG study of tibialis posterior and assessment of muscle strength using a force frame

Intervention type: DIAGNOSTIC_TEST
Intervention: Fine wire EMG and Force Frame muscle strength testing
Description: Insertion of fine wires for EMG study of tibialis posterior and assessment of muscle strength using a force frame
Study: NCT05520294

Intervention type: OTHER
Intervention: High-performance liquid chromatography-tandem mass spectrometry assays
Description: Paraffin blocks will be requested for slide creation, and at least 12 mL of whole blood will be collected in 2 green top tubes, centrifuged, and plasma transferred for storage at -80 C until further processing

Intervention type: OTHER
Intervention: High-performance liquid chromatography-tandem mass spectrometry assays
Description: Paraffin blocks will be requested for slide creation, and at least 12 mL of whole blood will be collected in 2 green top tubes, centrifuged, and plasma transferred for storage at -80 C until further processing
Study: NCT05217849

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi
Description: Tai Chi is an ancient Chinese form of exercise/martial art that involves a series of movements performed in a slow, focused manner and accompanied by deep breathing.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preventing Loss of Independence through Exercise (PLIE)
Description: PLIE is a gentle, mindful movement exercise program that integrates elements of Eastern and Western exercise modalities to develop mindful body awareness and enhance social connection.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health and Wellness Education
Description: This on-line class will consist of hour-long lectures/talks about various topics related to healthy aging and wellness.
Study: NCT05208554

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated health counseling and step prescription
Description: 8 weekly dyad-based sessions with a health counselor to train couples in the use of communal coping strategies to support one another in achieving physical activity goals plus individualized step prescription based on remotely-monitored Fitbit-derived step counts the week prior
Study: NCT06317935

Intervention type: OTHER
Group type: OTHER
Intervention: ArmeoSenso
Description: ArmeoSenso is an upper extremity virtual reality application with three motion sensors and one hand grip sensor. The device detects the person's body, arm, forearm and hand movements and displays the reflection of the movements on the screen. The application includes studies on upper extremity functions.

Intervention type: OTHER
Group type: OTHER
Intervention: Traditional Rehabilitation
Description: It includes traditional occupational therapy and physiotherapy approaches.

Intervention type: OTHER
Group type: OTHER
Intervention: Traditional Rehabilitation
Description: It includes traditional occupational therapy and physiotherapy approaches.
Study: NCT04738708

Intervention type: OTHER
Intervention: Patients referred to CGS at NCCS for HBOC or Lynch syndrome pre-test genetic counselling.
Description: Patients are given a series of questions evaluating cognitive and psychosocial outcomes, either via hardcopy in-person or online internet-facing questionnaire.
Study: NCT06168500

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Control group
Description: 4.0 diameter implant + guided bone regeneration
Study: NCT05624775

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Culinary Medicine
Description: The virtual curriculum will include five 90-minute sessions (to be held weekly or bi-weekly). Participants will cook and engage virtually (with video and sound on) from their home kitchens via the digital platform. Participants will also be expected to shop for groceries ahead of the sessions to participate in the program. A gift card will be provided for groceries ($20 per class = $100 total).Asynchronous virtual educational content (cooking skills videos, animated nutrition education videos, and additional recipes) will be provided to engage and retain participants beyond initial sessions. Recipes will provide enough food for a family of four. clinic patients
Study: NCT06129396

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: The aerobic exercise consists of: (1) 5 min warm-up exercise, (2) 20 min aerobic exercise with HR at target zone (one research assistant will be onsite to monitor whether the HR is around the range of moderate intensity), and (3) 5 min cool-down exercise.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Video-watching
Description: The video-watching group will be asked to watch a nature documentary for 30 mins
Study: NCT05123729

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Crowdsourced campaign package
Description: COVID-19 prevention intervention developed using a crowdsourcing process.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard information
Description: Standard informational videos promoting the adoption of health-protective behaviors and COVID-19 testing
Study: NCT06583850

Intervention type: OTHER
Intervention: The Neck Disability Index
Description: The Neck Disability Index (NDI) is the most widely used self-report tool to assess neck pain status, and provides information not only about pain experiences but also about a person\&#39;s functional status. The NDI consists of 10 questions related to pain, functional activities, self-care, and quality of life that are measured on a 6-point scale (0, no disability; 5, full disability). The numeric score for each item is summed for a score ranging from 0 to 50; 0-4 points are defined as no disability, 5-14 points as mild disability, 15-24 points as moderate disability, 25-34 points as severe disability and above 35 points as complete disability.

Intervention type: OTHER
Intervention: The Neck Disability Index
Description: The Neck Disability Index (NDI) is the most widely used self-report tool to assess neck pain status, and provides information not only about pain experiences but also about a person\&#39;s functional status. The NDI consists of 10 questions related to pain, functional activities, self-care, and quality of life that are measured on a 6-point scale (0, no disability; 5, full disability). The numeric score for each item is summed for a score ranging from 0 to 50; 0-4 points are defined as no disability, 5-14 points as mild disability, 15-24 points as moderate disability, 25-34 points as severe disability and above 35 points as complete disability.

Intervention type: OTHER
Intervention: Visual analog scale (VAS)
Description: A 10 cm VAS numbered from 0 to 10 was used for the assessment. 0 indicates no pain and 10 indicates unbearable pain. Participants were asked to mark a point between 0-10 according to their pain status

Intervention type: OTHER
Intervention: Visual analog scale (VAS)
Description: A 10 cm VAS numbered from 0 to 10 was used for the assessment. 0 indicates no pain and 10 indicates unbearable pain. Participants were asked to mark a point between 0-10 according to their pain status

Intervention type: OTHER
Intervention: Pittsburgh Sleep Quality Index
Description: Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a 19-item self-report questionnaire

Intervention type: OTHER
Intervention: Pittsburgh Sleep Quality Index
Description: Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a 19-item self-report questionnaire

Intervention type: OTHER
Intervention: Cervical Range of Motion Assessment
Description: Active Cervical Range Of Motion was measured with a universal goniometer in all three planes of motion in the cervical region: lateral flexion (frontal plane), axial rotation to both right and left sides (horizontal plane), and flexion-extension (sagittal plane).

Intervention type: OTHER
Intervention: Cervical Range of Motion Assessment
Description: Active Cervical Range Of Motion was measured with a universal goniometer in all three planes of motion in the cervical region: lateral flexion (frontal plane), axial rotation to both right and left sides (horizontal plane), and flexion-extension (sagittal plane).
Study: NCT05678855

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A randomızed Controlled Study with pre-test and post-test
Description: The intervention in this study is to apply multimedia-based instruction in distance education to the experimental group. control group students received distance education through traditional teaching. Experimental group students received distance education through interactive teaching prepared with multimedia tools. Experimental group, interactions were made using applications such as Icebreaker, Puzzle, QR code, Mentimeter, and Padlet. In addition, animation, infographics, animated slides (Multimedia tools) were used for the experimental group.In the control group, plain narration was given. Tests were administered to both groups before and after the intervention.
Study: NCT06254066

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab plus Fluzoparib
Description: Adebrelimab combined with Fluzoparib in HRD-positive HR +/HER2- advanced breast cancer
Study: NCT04260477

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6EH³R³Z
Description: A triple dose is defined as the triple of the routine dose used for a specific WHO weight band. Hence, the mg/kg within a weigh-band varies, as is the case in routine practice.~Dosing takings into consideration the fixed dose combination (FDC) tablets (one tablet: 150 mg R + 75 mg H + 400 mg Z + 275mg E). Dosage relies on tables with dosage by weight-bands used by WHO for the Cat. 1 regimen. The dosage used for the intensive phase of the Cat. 1 regimen applies for the whole treatment duration. A double dose of H and R is added to the recommended normal dose for adults (WHO,2003)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 6EHRZ
Description: Recommended normal dose adults (WHO, 2003)~* H: 5 (4-6) mg/kg/day~* R: 10 (8-12) mg/kg/day~* Z: 25 (20-30)mg/kg/day~* E: 15 (15-18)mg/kg/day
Study: NCT06048289

Intervention type: OTHER
Intervention: Blood samples, tumor biopsy specimens will be collected
Description: Blood samples, tumor biopsy specimens at baseline will be collected
Study: NCT05415020

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle Behavior Protocol
Description: Virtual training on building a skillset to improve lifestyle behavior that reduces migraine attacks

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Behavior Protocol
Description: Virtual training on the disease of migraine and how migraine can progress to chronic migraine.
Study: NCT06490692

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction Training
Description: The affected limb will have a cuff placed proximally and inflated to occlude the blood flow by 40% attested using a golden standard vascular doppler after which the individuals will perform the strengthening program set forth by the physical therapist. This is preceded by other tennis elbow interventions such as ultrasound, stretching, and deep friction massage at the extensor origin.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Strength Training
Description: The individuals in this group will undergo the same conventional physical therapy program as the other group including ultrasound, stretching, and deep friction massage. In addition, they will undergo the same strengthening program set forth by the physical therapist however with no blood flow restriction of any kind.
Study: NCT05388578

Intervention type: DEVICE
Intervention: Blood pressure monitor
Description: Participants will receive the Withings BPM connect monitor and do weekly self-measurements of blood pressure.

Intervention type: DEVICE
Intervention: Blood pressure monitor
Description: Participants will receive the Withings BPM connect monitor and do weekly self-measurements of blood pressure.

Intervention type: DEVICE
Intervention: Weighting scale
Description: Participants will receive the Withings Body scale and do weekly self-measurements of their body weight and BMI.

Intervention type: DEVICE
Intervention: Weighting scale
Description: Participants will receive the Withings Body scale and do weekly self-measurements of their body weight and BMI.

Intervention type: DEVICE
Intervention: Activity tracker
Description: Participants will receive the Withings Move to automatically keep track of their number of steps and activity type.

Intervention type: DEVICE
Intervention: Activity tracker
Description: Participants will receive the Withings Move to automatically keep track of their number of steps and activity type.

Intervention type: DEVICE
Intervention: ECG device
Description: Participants will receive the Withings Move ECG to make daily measurements of heart rhythm, an algorithm will detect abnormalities in heart rhythm such as atrial fibrillation.
Study: NCT04683237

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liraglutide Injection
Description: Initiate liraglutide with a dose of 0.6 mg daily for one week. After one week at 0.6 mg per day, increase the dose to 1.2 mg daily in a week, and increase the dose to 1.8 mg daily after at least one week of treatment with the 1.2 mg daily dose. If the patients can not tolerate 1.8mg per day, decrease the dose to the max tolerable dose.
Study: NCT06518876

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KQ-2003 CAR T-cells
Description: KQ-2003 CAR T-cell therapy involves autologous chimeric antigen receptor T-cells, capable of targeting both human B cell maturation antigen (anti-BCMA CAR) and CD19 antigen molecules (anti-CD19 CAR) simultaneously as a cellular therapy.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KQ-2003 CAR T-cells
Description: KQ-2003 CAR T-cell therapy involves autologous chimeric antigen receptor T-cells, capable of targeting both human B cell maturation antigen (anti-BCMA CAR) and CD19 antigen molecules (anti-CD19 CAR) simultaneously as a cellular therapy.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KQ-2003 CAR T-cells
Description: KQ-2003 CAR T-cell therapy involves autologous chimeric antigen receptor T-cells, capable of targeting both human B cell maturation antigen (anti-BCMA CAR) and CD19 antigen molecules (anti-CD19 CAR) simultaneously as a cellular therapy.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KQ-2003 CAR T-cells
Description: KQ-2003 CAR T-cell therapy involves autologous chimeric antigen receptor T-cells, capable of targeting both human B cell maturation antigen (anti-BCMA CAR) and CD19 antigen molecules (anti-CD19 CAR) simultaneously as a cellular therapy.
Study: NCT04683237

Intervention type: DRUG
Group type: OTHER
Intervention: Megestrol Acetate 160 MG
Description: 160mg po qd

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate 160 MG
Description: 160mg po qd
Study: NCT04794842

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tetracaine 5% drops
Description: same as information in the arm/group description

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Phenol 90% concentration
Description: same as information in the arm/group description
Study: NCT06180408

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual therapy and exercise for the big toe
Description: Maitland mobilization (Grade 3,4), Mulligan mobilization with movement techniques, muscle energy techniques, manual therapy for plantar fascia, strengthening exercises and self-stretching exercises was performed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lumbar stabilization exercise
Description: core training and myofascial release therapy
Study: NCT06486883

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan (T-DXd, DS-8201a)
Description: Patients will receive T-DXd 5.4 mg/kg body weight administered as an intravenous (IV) infusion on Day 1 (D1) of each 21-day cycle. The initial dose will be administered as a 90-minute IV infusion.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CDK4/6i plus ET
Description: Patients will receive physician's choice of CDK4/6 inhibitor (CDK4/6i) including palbociclib, ribociclib, and abemaciclib; physician's choice of endocrine therapy (ET) including fulvestrant, letrozole, anastrozole, and exemestane.
Study: NCT06410521

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Patients randomised to the intervention arm will undergo non-consecutive training sessions three times a week for a period of 12 weeks. The training session is divided into an aerobic and a resistance training component, with a 5-min warm-up (stretching exercises) and a 5-min cool-down (stretching and relaxing exercises). The cardiovascular component will comprise a progressive exercise duration from 30 to 40 minutes, an exercise intensity promoting moderate to severe claudication pain between 5-10 minutes, with rest time until the pain disappears, and a personalised load progression manipulated based on the claudication pain level, reaching a total of 50 minutes of walking per session. The resistance training component will comprise dynamic muscle contraction exercises (shoulders width squat, unilateral chair leg extension, and bilateral plantar flexion), with a load progression gradually increasing from one set of 10 repetitions to three sets of 15 repetitions.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Patients randomised to the active comparator arm will be advised about the importance of lifestyle modification (including general advice to increase walking but without specific recommendations about the exercise program) for a period of 12 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based exercise
Description: Patients who transitioned to the home-based exercise will undergo regular walking in or near the home at least three times week, with each walking taking approximately 30-40 minutes for a period of 12 weeks. The pace of intermittent walking will be self-selected in order to induce mild-to-moderate claudication pain between 5-10 minutes, with rest time until the pain disappears.
Study: NCT05672914

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tablet-based sustained care
Description: A tablet-based motivational-interviewing intervention, tailored specifically to smokers with psychiatric disorders, to motivate the use of evidence-based tobacco treatment and cessation in cigarette smokers upon discharge from an inpatient psychiatric hospitalization. In addition, participants will receive standard hospital tobacco care (see Usual Care Arm).
Study: NCT06089083

Intervention type: OTHER
Intervention: Physical function assessment
Description: Physical assessments of frailty will be conducted in person.

Intervention type: OTHER
Intervention: Self-reported Assessments and Questionnaires
Description: Quality of life questionnaires and self-reported measures will be provided to complete during the course of the study

Intervention type: PROCEDURE
Intervention: Surgery (Standard of Care, Non-Interventional)
Description: Surgical data will be reviewed via medical record
Study: NCT05307159

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: bean protein supplement
Description: They will have a snack with bean protein for 21 days Participants will follow their usual diet, which will be quantified and evaluated.
Study: NCT06470360

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Surgycal procedure
Description: surgical technique

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Surgycal procedure
Description: surgical technique
Study: NCT05715814

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 MG
Description: PO once daily
Study: NCT05156424

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: An individualised, progressive and autoregulated exercise programme, supervised by a trained professional.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: An individualised, progressive and autoregulated exercise programme, supervised by a trained professional.
Study: NCT05728008

Intervention type: DRUG
Intervention: Ustekinumab
Description: a human monoclonal antibody to interleukin IL 12/23 p40. It is indicated in the treatment of adult patients with moderately to severely active UC. The induction phase consists of approximately 6 mg/kg intravenous dose administration. After the induction, the maintenance phase consists of a 90mg subcutaneous dose every 8 weeks.

Intervention type: DRUG
Intervention: Tofacitinib
Description: Jak inhibitor. It is indicated in the treatment of adult patients with moderately to severely active UC who have experienced inadequate response or have lost the response or who are intolerant to conventional therapy or to a biological agent. The induction phase consists of 10mg twice daily for 8 to 16 weeks. After the induction, the maintenance phase consists of 5mg x twice daily.
Study: NCT04045236

Intervention type: OTHER
Intervention: Registry
Description: Data collection
Study: NCT06155916

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: Pregabalin administration and titration to the highest dosage that the patient tolerates. The patient continues with the highest dose for one month and the pre-intervention studies are repeated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: Pregabalin administration and titration to the highest dosage that the patient tolerates. The patient continues with the highest dose for one month and the pre-intervention studies are repeated.
Study: NCT05312931

Intervention type: OTHER
Intervention: OSCE
Description: Students undergo OSCE (objective structured clinical exams). It means students will perform CPR for 2 min and their success rate will be monitored.

Intervention type: OTHER
Intervention: OSCE
Description: Students undergo OSCE (objective structured clinical exams). It means students will perform CPR for 2 min and their success rate will be monitored.
Study: NCT05511220

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PRIMeR
Description: Virtual PRIMeR intervention consists of coaching parents to use strategies derived from Social Routines (to boost positive affect) and Reciprocal Imitation Training (to boost toy play)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PRT
Description: Virtual PRT intervention consists of coaching parents to use key PRT strategies to enhance children's communication skills